Development of a novel neonatal resuscitation monitor to ensure safe and effective provision of breathing support to newborn infants

开发新型新生儿复苏监测仪，确保为新生儿提供安全有效的呼吸支持

• 批准号: 10054756
• 金额: $ 43.46万
• 依托单位: EUROPLAZ TECHNOLOGIES LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10054756
• 关键词: Development; novel; neonatal; resuscitation; monitor

UK medical device SME, Europlaz is ISO13485 and has a core project team of Frede Jensen (Neonatal Medical Device Specialist), Ian Goodacre (Engineering Manager), Katharine O'Keeffe (Business Sponsor and Project Manager).Delivery room resuscitation is needed for 10% of newborns. Resuscitation of neonates is stressful and highly pressured, but clinicians do not have the equipment to enable them to accurately evaluate the baby's cardio-respiratory system and act accordingly. Three-quarters of newborn resuscitations are considered unsafe or below the accepted standard (Vaidya,2021 ). Total cost of maternity care claims are £4.2bn and brain damage during birth accounts for 39%, or £1.6bn. The lack of reliable, objective data hinders the evaluation of errors and limits opportunities for learning/improvement.Europlaz's solution is an intuitive, multiple-parameter, respiratory monitor to display tidal volume, C02 elimination, Sp02, dual (R/L) oxygenation and mask leak for even the smallest patients. The device enhances NICU capability and transfers skills to the under-served, low-tech delivery room.Real-time data is displayed as a straightforward bar graph, and export enables recording the resuscitation event for accountability and learning/improvement. Europlaz is bringing ICU technology (tidal volume/CO2) into the maternity ward.The Europlaz device will improve resuscitation efficiency and prevent volume induced lung and CO2 induced brain injuries. It will reduce the escalations of 2.2% of babies into high-intensive care and could save the NHS £15M in neonatal intensive care. The innovation compensates for staffing shortages and skills deficits.The project will increase R&D activity by 50% and will create 20+ jobs for a medical device manufacturing company producing life saving products here in the UK.

Europlaz的英国医疗设备中小企业是ISO13485，并拥有Frede Jensen（新生儿医疗设备专家），Ian Goodacre（工程经理），Katharine O'Keeffe（商业赞助商兼项目经理）。送达新生儿10％的核心复苏。新生儿的复苏压力很大且高度加压，但是临床医生没有设备使他们能够准确评估婴儿的心脏呼吸系统并采取相应的行动。四分之三的新生儿复苏被认为不安全或低于公认的标准（Vaidya，2021）。产妇护理索赔的总成本为42亿英镑，出生期间的脑部损害为39％，即16亿英镑。缺乏可靠的，客观的数据阻碍了错误的评估和限制学习/改进的机会。Europlaz的解决方案是直观的，多参数，呼吸显示器，以显示潮汐量，C02消除，SP02，Dual（R/L），氧气（R/L）的氧气和掩盖最小的患者的泄漏。该设备增强了NICU的功能，并将技能传递到服务不足的低技术交付室。真实的时间数据显示为直接的条形图，导出可以录制复苏事件以进行问责制和学习/改进。 Europlaz正在将ICU技术（潮汐量/CO2）带入产科病房。Europlaz设备将提高复苏效率，并防止体积引起的肺和CO2诱导的脑损伤。它将减少2.2％的婴儿升级到高密集型护理中，并可以节省NHS 1500万英镑的新生儿重症监护。创新弥补了人员短缺和技能缺陷。该项目将使研发活动增加50％，并将为在英国生产救生产品的医疗设备制造公司创造20多个就业机会。